GGrantIndex
← Leaderboards

Rhonda F Souza

Baylor Research Institute

$7,935,054
Attributed
$18,507,156
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,507,156 · 8
VA$0 · 3

By mechanism

R01$9,490,409 · 5
U01$8,184,774 · 1
R21$447,835 · 1
U34$384,138 · 1
I01$0 · 3

Most similar at Baylor Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Barrett Esophagus

Research focus

Barrett EsophagusGastroesophageal Reflux DiseaseEsophageal AdenocarcinomaMalignant NeoplasmsMetaplasiaEsophagusMolecularRisk FactorsPreventCellsTumor ProgressionTumorEpithelial CellsCell LineRefluxAcidsEsophagealIn VitroTelomeraseEventSquamous EpitheliumProton Pump InhibitorsIn VivoMediating

Grant awards (54)

A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial$1,742,655
U01 · FY2025 · DK
Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE study$577,120
R01 · FY2025 · DK · contact PI
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial$2,111,999
U01 · FY2024 · DK
Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE study$545,202
R01 · FY2024 · DK · contact PI
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial$2,130,120
U01 · FY2023 · DK
Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE study$592,690
R01 · FY2023 · DK · contact PI
The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency Ablation$360,968
R01 · FY2023 · DK · contact PI
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial$2,200,000
U01 · FY2022 · DK
The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency Ablation$360,968
R01 · FY2022 · DK · contact PI
The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency Ablation$360,968
R01 · FY2021 · DK · contact PI
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial$384,138
U34 · FY2020 · DK
The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency Ablation$360,968
R01 · FY2020 · DK · contact PI
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus$360,968
R01 · FY2019 · DK · contact PI
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus$360,968
R01 · FY2018 · DK · contact PI
Endoscopic, Histologic, and Molecular Characterization of Esophageal Wound Healing after Radiofrequency Ablation of Barrett's Esophagus$196,290
R21 · FY2018 · DK · contact PI
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus$0
I01 · FY2018 · VA
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus$360,968
R01 · FY2017 · DK · contact PI
Endoscopic, Histologic, and Molecular Characterization of Esophageal Wound Healing after Radiofrequency Ablation of Barrett's Esophagus$251,545
R21 · FY2017 · DK · contact PI
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus$0
I01 · FY2017 · VA
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus$249,865
R01 · FY2016 · DK · contact PI
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus$87,259
R01 · FY2016 · DK · contact PI
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus$0
I01 · FY2016 · VA
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus$283,500
R01 · FY2015 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$250,707
R01 · FY2015 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$77,147
R01 · FY2015 · DK · contact PI
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus$0
I01 · FY2015 · VA
Role of Acid in the Development of Barrett's Esophagus$274,050
R01 · FY2014 · DK · contact PI
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus$0
I01 · FY2014 · VA · contact PI
Role of Acid in the Development of Barrett's Esophagus$264,459
R01 · FY2013 · DK · contact PI
Basic and Clinical Studies on the Role of Bile Acids in Barrett's Esophagus$238,391
R01 · FY2013 · CA · contact PI
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus$0
I01 · FY2013 · VA · contact PI
Role of Acid in the Development of Barrett's Esophagus$274,050
R01 · FY2012 · DK · contact PI
Basic and Clinical Studies on the Role of Bile Acids in Barrett's Esophagus$253,607
R01 · FY2012 · CA · contact PI
Clinical Studies on Bile Acids in Barrett's Esophagus$0
I01 · FY2012 · VA
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus$0
I01 · FY2012 · VA · contact PI
Basic and Clinical Studies on the Role of Bile Acids in Barrett's Esophagus$253,607
R01 · FY2011 · CA · contact PI
Role of Acid in the Development of Barrett's Esophagus$242,663
R01 · FY2011 · DK · contact PI
Clinical Studies on Bile Acids in Barrett's Esophagus$0
I01 · FY2011 · VA
Role of IL-6/STAT3 Signaling in the Neoplastic Progression of Barrett's Esophagus$0
I01 · FY2011 · VA · contact PI
Clinical Studies on Bile Acids in Barrett's Esophagus$0
I01 · FY2011 · VA
Basic and Clinical Studies on the Role of Bile Acids in Barrett's Esophagus$261,450
R01 · FY2010 · CA · contact PI
Role of Acid in the Development of Barrett's Esophagus$245,114
R01 · FY2010 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$43,563
R01 · FY2010 · DK · contact PI
Basic and Clinical Studies on the Role of Bile Acids in Barrett's Esophagus$261,450
R01 · FY2009 · CA · contact PI
Role of Acid in the Development of Barrett's Esophagus$247,590
R01 · FY2009 · DK · contact PI
Clinical Studies on Bile Acids in Barrett's Esophagus$0
I01 · FY2009 · VA
Role of Acid in the Development of Barrett's Esophagus$216,090
R01 · FY2008 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$31,500
R01 · FY2008 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$252,000
R01 · FY2007 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$184,559
R01 · FY2006 · DK · contact PI
Role of Acid in the Development of Barrett's Esophagus$189,000
R01 · FY2005 · DK
Role of Acid in the Development of Barrett's Esophagus$189,000
R01 · FY2004 · DK
Role of Acid in the Development of Barrett's Esophagus$189,000
R01 · FY2003 · DK
Role of Acid in the Development of Barrett's Esophagus$189,000
R01 · FY2002 · DK